SCHEMBL6490228

SCHEMBL6490228

Cc1cc(Cc2ccc(C=O)cc2)cc(C)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.45
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 6/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A3 P47895 2/20 0.38
ALDH3A1 P30838 1/20 0.38
TYR P14679 1/20 0.36
CYP2A13 Q16696 1/20 0.36
DCTPP1 Q9H773 1/20 0.36
GRM2 Q14416 1/20 0.36
HSD17B10 Q99714 1/20 0.35
ALDH5A1 P51649 1/20 0.35
ABAT P80404 1/20 0.35
BRD4 O60885 1/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3721965 0.87 CYP2A6 (0.43) CYP2A6RAB9AALDH1A1LMNAMAPT
SCHEMBL17508269 0.80 CYP2A6 (0.54) CYP2A6RAB9AALDH1A1LMNAMAPT
SCHEMBL13008173 0.78 LMNA (0.40) RAB9ALMNAKDM4ECYP3A4CYP2C19
SCHEMBL3976211 0.78 CYP2A6 (0.52) CYP2A6RAB9AALDH1A1LMNAMAPT
SCHEMBL20546774 0.77 CYP2A6 (0.76) CYP2A6RAB9AALDH1A1LMNAMAPT
SCHEMBL25153861 0.77 HSD17B10 (0.45) CYP2A6RAB9AALDH1A1LMNAMAPT
SCHEMBL6490224 0.76 GRM2 (0.35) RAB9AALDH1A1GRM2KDM4ECYP3A4
SCHEMBL10730575 0.75 CALM1 (0.55) ALDH1A1MAPTSMN1; SMN2KMT2A
SCHEMBL3964970 0.74 CYP1A2 (0.51) RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL378339 0.74 SRC (0.42) CYP2A6ALDH1A1LMNATYRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed
EP-1373199-A4 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-04-07 EP disclosed
EP-1373199-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) Bristol-Myers Squibb Pharma Company (US) 2004-01-02 EP disclosed
WO-2002074738-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL-MYERS SQUIBB COMPANY (US) 2002-09-26 WO disclosed